OPTIMIZING SYSTEMIC LUPUS ERYTHEMATOSUS CARE WITH ARTIFICIAL INTELLIGENCE: A SYSTEMATIC REVIEW OF CLINICAL APPLICATIONS

PV145 / #693 Poster Topic: AS17 - Miscellaneous Background/Purpose Artificial Intelligence (AI) is revolutionizing healthcare, offering innovative solutions for early diagnosis, clinical and molecular phenotyping, prognosis prediction, and patient care optimization in different diseases, including Systemic Lupus Erythematosus (SLE). Machine Learning (ML) is a subset of AI that enables systems to learn from data and improve performance over time without being explicitly programmed. This study aims to analyze the state of the art on clinical applications of AI tools in patients with SLE. Methods A systematic literature review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement guidelines. The search was completed through MEDLINE, Scopus, and the Cochrane Library databases in November 2024. The search strategy employed various combinations of MeSH terms and keywords, including: “Artificial Intelligence,” “Machine Learning,” “Deep Learning,” “Artificial Neural Networks,” “Natural Language Processing,” “Large Language Model,” and “Systemic Lupus Erythematosus.” Studies were included if they met the following criteria: (1) abstract available, (2) contained original data, (3) included adult patients with SLE, and (4) incorporated AI-based methodologies or tools in their study design or analysis. Results Out of 1.022 articles identified in scientific databases, 60 fulfilled the eligibility criteria and were included in the analysis (Figure 1). These selected articles included a total of 61.273 SLE patients, in which aspects such as lupus nephritis (LN, n=16), diagnosis (n=7), biomarkers (n=6), extra-renal SLE (n=6), pregnancy (n=4), disease activity (n=3), Electronic Health Records (EHRs) analysis (n=3), flares (n=2), among others, were evaluated. Most studies were published between 2023 and 2024, with China and the USA being the most represented countries (Figure 2). ML was employed in the majority of the selected studies, accounting for 75% (45 out of 60) of the total, followed by Deep Learning (n=5), Artificial Neural Networks (n=4), Natural Language Processing (NLP, n=4), and Large Language Models (specifically ChatGPT) in 2 studies. AI, employing NLP algorithms, demonstrates the capacity to extract clinically relevant data from EHRs, thereby enhancing the identification and comprehensive clinical characterization of SLE patients. A total of 37.800 SLE patients were evaluated using ML techniques. Extreme Gradient Boosting (XGBoost), Random Forest, Logistic Regression, and Support Vector Machines were the most frequently utilized models. These models were applied to multiple aspects of the disease, focusing on LN, including biomarkers identification and prediction of proliferative lupus nephritis diagnosis, renal flares, coinfection, complete remission, and treatment response. In the context of SLE diagnosis, ML models effectively identified patterns in clinical data, predicting lupus probability and classifying patients into different diagnostic certainty levels. In the majority of cases, the performance of ML models was comparable or superior to traditional statistical models, as evaluated by area under the curve (AUC: range 0.63-0.98), accuracy (63.6-99.9%), precision (50.0-97.8%), sensitivity (35.0-99.3%), specificity (56.6-100%), and F1-Score (0.14-0.99, typically greater than 0.80). This review identifies data heterogeneity and publication bias as significant challenges that can impact the reliability and generalizability of these findings. Figure 1. Flowchart of Systematic Literature Review. Figure 2. Heat Map of Selected Articles on AI Applications in Systemic Lupus Erythematosus. Conclusions This systematic review highlights the role of AI, especially ML, in advancing the clinical management of SLE. The results demonstrate that ML models significantly enhance diagnostic accuracy and patient care, often surpassing traditional statistical methods. Understanding the limitations of AI tools is crucial before their implementation in clinical practice.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.